Ridding yourself of Restless Leg Syndrome (w/ Video)

Dec 03, 2010 By Keith Herrell

It makes no sense: You’ve had a long day, and you’re ready for a restful night’s sleep. But as you lie in bed, you experience an uncontrollable urge to move your legs—perhaps accompanied by unpleasant sensations such as tingling, crawling or even pain.

You may have (RLS), a neurological condition that is classified as a movement disorder, like Parkinson’s disease or essential tremor. There is no known single cause, but it is associated with dysfunction of the neurotransmitter known as dopamine at the spinal cord level.

The actual prevalence of RLS is not known, but according to the RLS Foundation, positive response rates for the question, "Do you have a creepy, crawly sensation in your legs at night when you attempt to sleep?” are between 3 and 15 percent.

"The vast majority of people don’t necessarily look for treatment,” says Alberto Espay, MD, a UC Health neurologist and member of the UC Neuroscience Institute. "They may feel like it’s all in their head, or decide that it’s something they’re willing to live with rather than see a doctor.

This video is not supported by your browser at this time.
Alberto Espay, MD, discusses Restless Leg Syndrome.

"But RLS does respond to treatment in the overwhelming majority of people, enabling them to improve the quality of their sleep substantially—and with it, enjoy an improvement in their daytime functioning.”

A diagnosis of RLS usually involves four criteria, according to the RLS Foundation: an uncontrollable urge to move your legs, accompanied by uncomfortable sensations; the sensations begin or get worse during periods of rest; the symptoms get better when you move your legs; and the symptoms are worse in the evening.

RLS often runs in families, researchers say, and also may appear as the result of another condition such as pregnancy or end-stage renal disease with dialysis.

There are no lab tests to determine if you have RLS. If you visit a doctor, he or she will likely review your medical history, conduct a diagnostic interview and rule out any conditions that might be confused with RLS. In addition, you might be asked to stay overnight in a sleep lab.

Dopamine agonists, which mimic the effects of dopamine in the brain, are the first line of pharmacological treatment, Espay says. The two commercially available (by prescription) are pramipexole (brand name Mirapex) and ropinirole (brand name Requip).

Other drugs, such as those used to treat nerve disorders, are prescribed if dopamine agonists are ineffective or have intolerable side effects, Espay says. Also, gabapentin, benzodiazepines such as clonazepam or, if needed, opioids such as oxycodone and propoxyphene—medications typically associated with the treatment of pain—can be helpful for those who are unable to benefit from dopamine agonists.

"Treatment for RLS typically relies on a low dose of medication taken by pill at bedtime, and people may not ever need an adjustment,” Espay says. "So it’s really a good idea to consider visiting a doctor if you have any kind of symptoms that are taking you away from a good night’s sleep.”

Explore further: Losing weight may ease chronic heartburn

add to favorites email to friend print save as pdf

Related Stories

Race is strong predictor for restless legs syndrome

Nov 02, 2009

New research shows that Caucasian women may suffer from restless legs syndrome (RLS), a sleep disorder characterized by the strong urge to move the legs, up to four times more than African-American women. The study, presented ...

Recommended for you

Researchers find genetic risk factor for pulmonary fibrosis

4 hours ago

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibros ...

Biomarkers discovered for inflammatory bowel disease

4 hours ago

Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...

CDC says high number of public pools contain microbes

5 hours ago

(HealthDay)—Three-quarters of public schools in the metro Atlanta area contain microbes, including bacteria indicating the presence of fecal matter, according to research published in the May 17 issue of ...

Study examines outbreak of spinal infections in Michigan

5 hours ago

(HealthDay)—Factors such as increased case finding may explain why Michigan had half of the total spinal infections associated with contaminated methylprednisolone acetate in the recent fungal meningitis ...

World not ready for mass flu outbreak, WHO says

5 hours ago

The world is unprepared for a massive virus outbreak, the deputy chief of the World Health Organization warned Tuesday, amid fears that H7N9 bird flu striking China could morph into a form that spreads easily among people.

User comments : 0

More news stories

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

New method for producing clean hydrogen

Duke University engineers have developed a novel method for producing clean hydrogen, which could prove essential to weaning society off of fossil fuels and their environmental implications.